🎙️ We’re back with the twelfth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this week’s episode, Bas examines whether today’s clinical study assessments are truly prepared for the future of Parkinson’s research and care. With rapid advances in technology, emerging biomarkers, and new digital tools, long-established rating scales and outcome measures are increasingly being questioned.

Do they genuinely reflect what matters most to people living with Parkinson’s? And how might clinical studies adapt to capture the full complexity of the condition?

And don’t forget, you can listen here:

Amazon Music: https://music.amazon.co.uk/podcasts/34ec09bc-c8b8-4a28-a12b-ca8aae3edd57/parkinson-weekly?ref=dm_sh_BpcE171Aj6Bvc6jQNKL90yl8o

Spotify: https://open.spotify.com/show/5FVqV671ESQ5VxbncsIxIS?si=a29cb8d5e72640de

Apple: https://podcasts.apple.com/gb/podcast/parkinson-weekly/id1836115672

Have a question you’d like Bas to answer in a future episode? Email us at parkinsonweekly@gmail.com – we’d love to hear from you.